334 related articles for article (PubMed ID: 32517051)
1. The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.
Prabhu SA; Moussa O; Miller WH; Del Rincón SV
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517051
[No Abstract] [Full Text] [Related]
2. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction.
Shveygert M; Kaiser C; Bradrick SS; Gromeier M
Mol Cell Biol; 2010 Nov; 30(21):5160-7. PubMed ID: 20823271
[TBL] [Abstract][Full Text] [Related]
3. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Huang F; Gonçalves C; Bartish M; Rémy-Sarrazin J; Issa ME; Cordeiro B; Guo Q; Emond A; Attias M; Yang W; Plourde D; Su J; Gimeno MG; Zhan Y; Galán A; Rzymski T; Mazan M; Masiejczyk M; Faber J; Khoury E; Benoit A; Gagnon N; Dankort D; Journe F; Ghanem GE; Krawczyk CM; Saragovi HU; Piccirillo CA; Sonenberg N; Topisirovic I; Rudd CE; Miller WH; Del Rincón SV
J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690739
[No Abstract] [Full Text] [Related]
5. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
Zhan Y; Guo J; Yang W; Goncalves C; Rzymski T; Dreas A; Żyłkiewicz E; Mikulski M; Brzózka K; Golas A; Kong Y; Ma M; Huang F; Huor B; Guo Q; da Silva SD; Torres J; Cai Y; Topisirovic I; Su J; Bijian K; Alaoui-Jamali MA; Huang S; Journe F; Ghanem GE; Miller WH; Del Rincón SV
J Clin Invest; 2017 Nov; 127(11):4179-4192. PubMed ID: 29035277
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.
Zheng J; Li J; Xu L; Xie G; Wen Q; Luo J; Li D; Huang D; Fan S
PLoS One; 2014; 9(2):e89220. PubMed ID: 24551240
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo.
Waskiewicz AJ; Johnson JC; Penn B; Mahalingam M; Kimball SR; Cooper JA
Mol Cell Biol; 1999 Mar; 19(3):1871-80. PubMed ID: 10022874
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of eIF4E phosphorylation reduces cell growth and proliferation in primary central nervous system lymphoma cells.
Muta D; Makino K; Nakamura H; Yano S; Kudo M; Kuratsu J
J Neurooncol; 2011 Jan; 101(1):33-9. PubMed ID: 20499137
[TBL] [Abstract][Full Text] [Related]
9. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells.
Ishida M; Ishida T; Nakashima H; Miho N; Miyagawa K; Chayama K; Oshima T; Kambe M; Yoshizumi M
Circ Res; 2003 Dec; 93(12):1218-24. PubMed ID: 14605021
[TBL] [Abstract][Full Text] [Related]
10. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA.
Phillips A; Blaydes JP
Oncogene; 2008 Mar; 27(11):1645-9. PubMed ID: 17828301
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Huang F; Gonçalves C; Bartish M; Rémy-Sarrazin J; Issa ME; Cordeiro B; Guo Q; Emond A; Attias M; Yang W; Plourde D; Su J; Gimeno MG; Zhan Y; Galán A; Rzymski T; Mazan M; Masiejczyk M; Faber J; Khoury E; Benoit A; Gagnon N; Dankort D; Journe F; Ghanem GE; Krawczyk CM; Saragovi HU; Piccirillo CA; Sonenberg N; Topisirovic I; Rudd CE; Miller WH; Del Rincón SV
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690225
[TBL] [Abstract][Full Text] [Related]
12. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.
Ueda T; Watanabe-Fukunaga R; Fukuyama H; Nagata S; Fukunaga R
Mol Cell Biol; 2004 Aug; 24(15):6539-49. PubMed ID: 15254222
[TBL] [Abstract][Full Text] [Related]
13. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
D'Abronzo LS; Bose S; Crapuchettes ME; Beggs RE; Vinall RL; Tepper CG; Siddiqui S; Mudryj M; Melgoza FU; Durbin-Johnson BP; deVere White RW; Ghosh PM
Oncogene; 2017 Nov; 36(46):6359-6373. PubMed ID: 28745319
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
[TBL] [Abstract][Full Text] [Related]
16. Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway.
Liu Z; Li Y; Lv C; Wang L; Song H
Biochem Biophys Res Commun; 2016 Sep; 478(2):893-9. PubMed ID: 27520370
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1.
Batool A; Majeed ST; Aashaq S; Majeed R; Bhat NN; Andrabi KI
Mol Cell Biochem; 2020 Feb; 465(1-2):13-26. PubMed ID: 31782083
[TBL] [Abstract][Full Text] [Related]
18. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.
Pyronnet S; Imataka H; Gingras AC; Fukunaga R; Hunter T; Sonenberg N
EMBO J; 1999 Jan; 18(1):270-9. PubMed ID: 9878069
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.
Fan W; Wang W; Mao X; Chu S; Feng J; Xiao D; Zhou J; Fan S
J Neurooncol; 2017 Feb; 131(3):485-493. PubMed ID: 27900644
[TBL] [Abstract][Full Text] [Related]
20. MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells.
Huang XB; Yang CM; Han QM; Ye XJ; Lei W; Qian WB
Acta Pharmacol Sin; 2018 Dec; 39(12):1894-1901. PubMed ID: 30297804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]